RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mail| Auction date | 2026-06-26 |
| Loan | 3113 |
| Coupon | 0.125 % |
| ISIN-code | SE0009548704 |
| Maturity | 2027-12-01 |
| Tendered volume, SEK mln | 200 +/- 200 |
| Total bid volume, SEK mln | 800 |
| Volume sold, SEK mln | 200 |
| Number of bids | 7 |
| Number of accepted bids | 1 |
| Average yield | 0.990 % |
| Lowest yield | 0.990 % |
| Highest accepted yield | 0.990 % |
| % accepted at highest yield | 100.00 |
| Auction date | 2026-06-26 |
| Loan | 3114 |
| Coupon | 0.125 % |
| ISIN-code | SE0013748258 |
| Maturity | 2030-06-01 |
| Tendered volume, SEK mln | 200 +/- 200 |
| Total bid volume, SEK mln | 650 |
| Volume sold, SEK mln | 200 |
| Number of bids | 10 |
| Number of accepted bids | 3 |
| Average yield | 0.645 % |
| Lowest yield | 0.630 % |
| Highest accepted yield | 0.650 % |
| % accepted at highest yield | 100.00 |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
- Cardano Price Prediction: ADA Holds Onto Weekly Gains as Remittix Targets Its Next Major Breakout
- Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
